Impact of renal function on antidiabetic drug selection in Japan: A real-world analysis using the J-DREAMS database.

Masashi Kubota; Mitsuru Ohsugi; Kohjiro Ueki

doi:10.1111/jdi.70280

February 27, 2026

Impact of renal function on antidiabetic drug selection in Japan: A real-world analysis using the J-DREAMS database.

View at Publisher

Ask AI

Bookmark

Share

Key Points

The research aims to analyze how renal function influences the choice of antidiabetic medications in Japan.
Analyzed data from the J-DREAMS database
Examined prescribing patterns of antidiabetic drugs
Focused on the relationship between renal function and medication selection
Increased prescription of SGLT2 inhibitors and GLP-1 receptor agonists
Medications are more frequently tailored according to renal function
Shift in prescribing patterns reflects adaptation to patient needs

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Real-world analysis shows tailored antidiabetic drug selection based on renal function, indicating effective treatment strategies in Japan.

Abstract

Prescribing patterns in Japan have shifted toward earlier use of SGLT2 inhibitors and GLP-1 receptor agonists, with medications appropriately tailored to renal function.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kubota et al. (2026) studied this question.

synapsesocial.com/papers/69a3d824ec16d51705d2ebb5 https://doi.org/10.1111/jdi.70280

View at Publisher

Ask AI

Bookmark

Share

Impact of renal function on antidiabetic drug selection in Japan: A real-world analysis using the J-DREAMS database.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Impact of renal function on antidiabetic drug selection in Japan: A real-world analysis using the J-DREAMS database.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading